Table 4: Multiple regression analysis of differences between SAO and ROO formulations.
CI: confidence interval, SAO: short-acting opioid, ROO: rapid-onset opioid.
R2: 0.780, p = < .0001. Each questionnaire item is evaluated at four levels (1: have no idea, 2: do not know much about, 3: well, I know, 4: know enough). The initial level "1" as the control level (baseline level), the value of each parameter represents the effect of increasing the level by one on the response.
variable level β standard error 95% CI of β t value p value
⑥Starting dose does not depend on the daily dose of the opioid analgesic being administered on time 2 0.540 0.634 -0.712 1.793 0.85 0.395
3 0.402 0.356 -0.302 1.105 1.13 0.261
4 0.659 0.326 0.014 1.305 2.02 0.045
⑨Restriction of the number of doses 2 0.941 0.532 -0.111 1.992 1.77 0.079
3 0.423 0.328 -0.225 1.070 1.29 0.199
4 1.029 0.349 0.338 1.719 2.94 0.004
⑪Duration of effect 2 0.278 0.574 -0.856 1.412 0.48 0.629
3 0.610 0.279 0.058 1.162 2.18 0.031
4 1.062 0.391 0.289 1.836 2.72 0.007
⑫Drug intake method (Abstral® sublingual tablets) 2 0.342 0.424 -0.496 1.180 0.81 0.421
3 0.607 0.295 0.024 1.190 2.06 0.042
4 0.007 0.359 -0.701 0.716 0.02 0.984
⑰Approximate cost 2 0.425 0.252 -0.073 0.924 1.69 0.094
3 -0.015 0.299 -0.606 0.576 -0.05 0.961
4 1.421 0.524 0.386 2.456 2.71 0.008
Occupations Physicians 0.087 0.198 -0.305 0.479 0.44 0.662
Nurses -0.494 0.167 -0.824 -0.165 -2.97 0.004
Pharmacists 0.407 0.150 0.110 0.705 2.71 0.008
Constant 0.537 0.398 -0.251 1.324 1.35 0.180